Cargando…

Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial

BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atheroscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Babaahmadi-Rezaei, Hossein, Kheirollah, Alireza, Hesam, Saeed, Ayashi, Saleh, Aberumand, Mohammad, Adel, Mohammad Hassan, Zamanpour, Masoumeh, Alasvand, Maryam, Amozgari, Zohreh, Noor-Behbahani, Mojgan, Niknam, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867307/
https://www.ncbi.nlm.nih.gov/pubmed/33598035
http://dx.doi.org/10.22122/arya.v16i4.2011
_version_ 1783648272810770432
author Babaahmadi-Rezaei, Hossein
Kheirollah, Alireza
Hesam, Saeed
Ayashi, Saleh
Aberumand, Mohammad
Adel, Mohammad Hassan
Zamanpour, Masoumeh
Alasvand, Maryam
Amozgari, Zohreh
Noor-Behbahani, Mojgan
Niknam, Zahra
author_facet Babaahmadi-Rezaei, Hossein
Kheirollah, Alireza
Hesam, Saeed
Ayashi, Saleh
Aberumand, Mohammad
Adel, Mohammad Hassan
Zamanpour, Masoumeh
Alasvand, Maryam
Amozgari, Zohreh
Noor-Behbahani, Mojgan
Niknam, Zahra
author_sort Babaahmadi-Rezaei, Hossein
collection PubMed
description BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis. METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received 1600 mg of powdered ginger or placebo (wheat flour) in capsules daily for 8 weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention. RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (27.25 ± 1.30 ng/ml vs. 23.57 ± 0.97 ng/ml) (P = 0.040) and also the level of hs-CRP in the intervention group was 1.90 ± 0.33 µg/ml and 1.24 ± 0.15 µg/ml (P = 0.010) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was 0.71 ± 0.05 mM and after the trial was 0.57 ± 0.04 mM (P = 0.050); no significant differences were seen in TAC when ginger was administered at 1600 mg/daily for 60 days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention. CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger.
format Online
Article
Text
id pubmed-7867307
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-78673072021-02-16 Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial Babaahmadi-Rezaei, Hossein Kheirollah, Alireza Hesam, Saeed Ayashi, Saleh Aberumand, Mohammad Adel, Mohammad Hassan Zamanpour, Masoumeh Alasvand, Maryam Amozgari, Zohreh Noor-Behbahani, Mojgan Niknam, Zahra ARYA Atheroscler Original Article BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis. METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received 1600 mg of powdered ginger or placebo (wheat flour) in capsules daily for 8 weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention. RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (27.25 ± 1.30 ng/ml vs. 23.57 ± 0.97 ng/ml) (P = 0.040) and also the level of hs-CRP in the intervention group was 1.90 ± 0.33 µg/ml and 1.24 ± 0.15 µg/ml (P = 0.010) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was 0.71 ± 0.05 mM and after the trial was 0.57 ± 0.04 mM (P = 0.050); no significant differences were seen in TAC when ginger was administered at 1600 mg/daily for 60 days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention. CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2020-07 /pmc/articles/PMC7867307/ /pubmed/33598035 http://dx.doi.org/10.22122/arya.v16i4.2011 Text en © 2020 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Babaahmadi-Rezaei, Hossein
Kheirollah, Alireza
Hesam, Saeed
Ayashi, Saleh
Aberumand, Mohammad
Adel, Mohammad Hassan
Zamanpour, Masoumeh
Alasvand, Maryam
Amozgari, Zohreh
Noor-Behbahani, Mojgan
Niknam, Zahra
Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title_full Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title_fullStr Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title_full_unstemmed Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title_short Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial
title_sort decreased lipoprotein (a) and serum high-sensitivity c-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867307/
https://www.ncbi.nlm.nih.gov/pubmed/33598035
http://dx.doi.org/10.22122/arya.v16i4.2011
work_keys_str_mv AT babaahmadirezaeihossein decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT kheirollahalireza decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT hesamsaeed decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT ayashisaleh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT aberumandmohammad decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT adelmohammadhassan decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT zamanpourmasoumeh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT alasvandmaryam decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT amozgarizohreh decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT noorbehbahanimojgan decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial
AT niknamzahra decreasedlipoproteinaandserumhighsensitivitycreactiveproteinlevelsinmalepatientswithatherosclerosisaftersupplementationwithgingerarandomizedcontrolledtrial